Hypertension Trial, Recruiting

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

• You are 40 years old or older and have mild to moderate open-angle glaucoma that is not well controlled
• Your eye pressure is 18 mmHg or higher, even while using at least one eye drop medication to lower it
• Your eye examination shows an open drainage angle in the eye (confirmed by a special eye exam called gonioscopy)
• Your cornea (the clear front part of your eye) is clear and the surface of your eye is healthy
• You are able and willing to give your consent, take part in the trial, and attend follow-up appointments
• You have glaucoma-related vision field loss in one or both eyes, confirmed by at least two consistent vision tests
• The tissue on the surface of your eye (in the upper area) is healthy and movable
• Your best corrected vision is at least 20/100 (meaning you can see with glasses or contacts to a reasonable level)
• Your vision field loss is not worse than a certain level, and you do not have a specific pattern of central vision loss (confirm with trial site)
• You are not expected to need any other eye surgery (such as cataract surgery) within 3 months of joining the trial

Who may not be able to join:

• You have previously had glaucoma surgery (such as a trabeculectomy, shunt, or valve) in the area of the eye being treated
• You have a type of glaucoma caused by closed drainage angles, abnormal blood vessels, eye inflammation, or injury
• The surface of your eye in the treatment area has scarring, has had surgery before, or has other problems
• The white of your eye (sclera) in the treatment area is abnormally thin or has structural problems
• Your eye pressure is higher than 35 mmHg at your screening appointment
• You currently have an active eye infection or inflammation (such as eyelid, conjunctival, corneal, or internal eye inflammation)
• You have had abnormal new blood vessel growth in the iris (coloured part of the eye) in the past 6 months
• You have a problem with the drainage of blood vessels on the surface of your eye (confirm with trial site)
• You have a certain type of lens implant located at the front of your eye (anterior chamber intraocular lens)
• You have a bleeding disorder that is not controlled, or you are taking blood-thinning medication without proper management around the time of any procedure
• You have severe, advanced glaucoma damage to your optic nerve
• You have a specific corneal condition (Fuchs endothelial dystrophy) that is showing signs of the cornea breaking down
• The thickness of your cornea is greater than 600 μm (a measurement taken during an eye exam)
• You have a severe level of short-sightedness classified as pathological myopia
• You are not able to follow post-procedure care instructions or attend follow-up visits
• You are pregnant, breastfeeding, planning to become pregnant, or are of childbearing age and not using a reliable form of contraception (certain contraceptive methods must have been in use for a specific period before the study begins — confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.